Literature DB >> 23113478

A shift on "pay for delay"--reopening doors for pharmaceutical competition?

Erica J Hemphill Kraus1.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23113478     DOI: 10.1056/NEJMp1209693

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Are reverse payments and pay-for-delay settlements business as usual or an anticompetitive practice?

Authors:  Swati Shah; Matthew A Silva; Michael J Malloy
Journal:  Nat Biotechnol       Date:  2016-07-12       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.